August 30, 2024 07:00 AM EDTUpdated 11:00 AM
Peer Review

J&J's hu­man re­sources leader to re­tire; Am­gen be­comes the newest phar­ma with a top AI ex­ec

Alex Hoffman

Senior Editor

Kathy Wong

Editor

→ Kris­ten Mul­hol­land will take over for the re­tir­ing Pe­ter Fa­so­lo as chief hu­man re­sources of­fi­cer at J&J on Oct. 1. “Pe­ter has led J …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

SEC probe of Il­lu­mi­na’s Grail deal tar­gets sales fore­casts, sources say

Ex­clu­sive: A male con­tra­cep­tive may pre­vent 99% of preg­nan­cies. Now it’s up to a small biotech to fin­ish test­ing it

House pass­es Biose­cure Act, send­ing Chi­nese biotech ban to Sen­ate

GSK, iTeos re­ju­ve­nate strug­gling TIG­IT space with pos­i­tive Phase 2 Jem­per­li com­bo da­ta in lung can­cer

Ad­comm says In­ter­cep­t's rare liv­er dis­ease drug should not get full ap­proval

#ES­MO24 roundup: New da­ta on Am­gen’s PRMT5 in­hibitor seem lack­lus­ter, and Jazz’s HER2 an­ti­body

A service from the Financial Times